vs
AIR LEASE CORP（AL）与Ascendis Pharma A/S（ASND）财务数据对比。点击上方公司名可切换其他公司
Ascendis Pharma A/S的季度营收约是AIR LEASE CORP的1.9倍（$267.3M vs $140.8M），AIR LEASE CORP同比增速更快（90.4% vs 42.3%），过去两年AIR LEASE CORP的营收复合增速更高（69.6% vs 60.7%）
航空租赁公司（ALC）是2010年成立的美国飞机租赁企业，由史蒂文·F·乌德瓦-哈齐执掌运营。公司直接向波音、空客、巴航工业、ATR采购全新商用飞机，为全球各地航空公司客户提供专业的飞机租赁及融资服务。
Ascendis Pharma A/S是一家聚焦内分泌疾病治疗领域的生物制药企业，核心业务覆盖生长激素疗法的研发、生产与商业化。其依托重组DNA技术生产的生长激素类处方药物，可用于治疗多种生长激素缺乏相关适应症，临床应用场景广泛。
AL vs ASND — 直观对比
营收规模更大
ASND
是对方的1.9倍
$140.8M
营收增速更快
AL
高出48.1%
42.3%
两年增速更快
AL
近两年复合增速
60.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $140.8M | $267.3M |
| 净利润 | $180.9M | — |
| 毛利率 | — | 90.5% |
| 营业利润率 | — | — |
| 净利率 | 128.5% | — |
| 营收同比 | 90.4% | 42.3% |
| 净利润同比 | 60.2% | — |
| 每股收益（稀释后） | $1.49 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALASND
| Q4 25 | $140.8M | $267.3M | ||
| Q3 25 | $44.5M | $230.7M | ||
| Q2 25 | $53.0M | $170.7M | ||
| Q1 25 | $92.9M | $109.0M | ||
| Q4 24 | $74.0M | $187.8M | ||
| Q3 24 | $65.0M | $62.5M | ||
| Q2 24 | $57.8M | $38.9M | ||
| Q1 24 | $49.0M | $103.6M |
净利润ALASND
| Q4 25 | $180.9M | — | ||
| Q3 25 | $146.5M | $-65.9M | ||
| Q2 25 | $385.2M | $-42.0M | ||
| Q1 25 | $375.8M | $-102.2M | ||
| Q4 24 | $112.9M | — | ||
| Q3 24 | $104.0M | $-107.1M | ||
| Q2 24 | $102.9M | $-118.1M | ||
| Q1 24 | $107.9M | $-141.5M |
毛利率ALASND
| Q4 25 | — | 90.5% | ||
| Q3 25 | — | 89.5% | ||
| Q2 25 | — | 80.1% | ||
| Q1 25 | — | 82.6% | ||
| Q4 24 | — | 91.9% | ||
| Q3 24 | — | 80.6% | ||
| Q2 24 | — | 68.2% | ||
| Q1 24 | — | 92.1% |
营业利润率ALASND
| Q4 25 | — | — | ||
| Q3 25 | — | 5.1% | ||
| Q2 25 | — | -33.5% | ||
| Q1 25 | — | -103.2% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -167.3% | ||
| Q2 24 | — | -370.2% | ||
| Q1 24 | — | -51.2% |
净利率ALASND
| Q4 25 | 128.5% | — | ||
| Q3 25 | 329.2% | -28.5% | ||
| Q2 25 | 726.9% | -24.6% | ||
| Q1 25 | 404.5% | -93.7% | ||
| Q4 24 | 152.7% | — | ||
| Q3 24 | 160.0% | -171.5% | ||
| Q2 24 | 178.2% | -303.9% | ||
| Q1 24 | 220.2% | -136.6% |
每股收益（稀释后）ALASND
| Q4 25 | $1.49 | — | ||
| Q3 25 | $1.21 | — | ||
| Q2 25 | $3.33 | — | ||
| Q1 25 | $3.26 | — | ||
| Q4 24 | $0.83 | — | ||
| Q3 24 | $0.82 | — | ||
| Q2 24 | $0.81 | — | ||
| Q1 24 | $0.87 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.4M | $665.3M |
| 总债务越低越好 | $19.7B | — |
| 股东权益账面价值 | $8.5B | $-175.8M |
| 总资产 | $32.9B | $1.4B |
| 负债/权益比越低杠杆越低 | 2.33× | — |
8季度趋势，按日历期对齐
现金及短期投资ALASND
| Q4 25 | $466.4M | $665.3M | ||
| Q3 25 | $452.2M | $582.2M | ||
| Q2 25 | $454.8M | $533.6M | ||
| Q1 25 | $456.6M | $559.4M | ||
| Q4 24 | $472.6M | $604.3M | ||
| Q3 24 | $460.8M | $675.6M | ||
| Q2 24 | $454.1M | $279.4M | ||
| Q1 24 | $554.4M | $345.9M |
总债务ALASND
| Q4 25 | $19.7B | — | ||
| Q3 25 | $20.2B | — | ||
| Q2 25 | $20.3B | — | ||
| Q1 25 | $19.9B | — | ||
| Q4 24 | $20.2B | — | ||
| Q3 24 | $20.2B | — | ||
| Q2 24 | $19.7B | — | ||
| Q1 24 | $19.5B | — |
股东权益ALASND
| Q4 25 | $8.5B | $-175.8M | ||
| Q3 25 | $8.3B | $-188.0M | ||
| Q2 25 | $8.2B | $-202.6M | ||
| Q1 25 | $7.9B | $-205.0M | ||
| Q4 24 | $7.5B | $-114.2M | ||
| Q3 24 | $7.7B | $-105.1M | ||
| Q2 24 | $7.3B | $-346.8M | ||
| Q1 24 | $7.2B | $-257.2M |
总资产ALASND
| Q4 25 | $32.9B | $1.4B | ||
| Q3 25 | $33.4B | $1.2B | ||
| Q2 25 | $33.3B | $1.2B | ||
| Q1 25 | $32.4B | $1.1B | ||
| Q4 24 | $32.3B | $1.3B | ||
| Q3 24 | $32.2B | $1.2B | ||
| Q2 24 | $31.0B | $819.0M | ||
| Q1 24 | $30.9B | $866.7M |
负债/权益比ALASND
| Q4 25 | 2.33× | — | ||
| Q3 25 | 2.42× | — | ||
| Q2 25 | 2.47× | — | ||
| Q1 25 | 2.53× | — | ||
| Q4 24 | 2.68× | — | ||
| Q3 24 | 2.63× | — | ||
| Q2 24 | 2.69× | — | ||
| Q1 24 | 2.69× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $414.1M | $58.2M |
| 自由现金流经营现金流 - 资本支出 | $342.1M | — |
| 自由现金流率自由现金流/营收 | 242.9% | — |
| 资本支出强度资本支出/营收 | 51.1% | — |
| 现金转化率经营现金流/净利润 | 2.29× | — |
| 过去12个月自由现金流最近4个季度 | $1.5B | — |
8季度趋势，按日历期对齐
经营现金流ALASND
| Q4 25 | $414.1M | $58.2M | ||
| Q3 25 | $458.6M | — | ||
| Q2 25 | $473.6M | — | ||
| Q1 25 | $388.3M | $-15.5M | ||
| Q4 24 | $430.0M | $-330.7M | ||
| Q3 24 | $461.9M | — | ||
| Q2 24 | $413.8M | — | ||
| Q1 24 | $371.3M | $-109.7M |
自由现金流ALASND
| Q4 25 | $342.1M | — | ||
| Q3 25 | $412.3M | — | ||
| Q2 25 | $427.1M | — | ||
| Q1 25 | $315.5M | — | ||
| Q4 24 | $326.8M | — | ||
| Q3 24 | $369.8M | — | ||
| Q2 24 | $346.4M | — | ||
| Q1 24 | $246.8M | — |
自由现金流率ALASND
| Q4 25 | 242.9% | — | ||
| Q3 25 | 926.6% | — | ||
| Q2 25 | 806.0% | — | ||
| Q1 25 | 339.5% | — | ||
| Q4 24 | 441.8% | — | ||
| Q3 24 | 569.1% | — | ||
| Q2 24 | 599.5% | — | ||
| Q1 24 | 503.8% | — |
资本支出强度ALASND
| Q4 25 | 51.1% | — | ||
| Q3 25 | 104.1% | — | ||
| Q2 25 | 87.8% | — | ||
| Q1 25 | 78.4% | — | ||
| Q4 24 | 139.6% | — | ||
| Q3 24 | 141.7% | — | ||
| Q2 24 | 116.7% | — | ||
| Q1 24 | 254.3% | — |
现金转化率ALASND
| Q4 25 | 2.29× | — | ||
| Q3 25 | 3.13× | — | ||
| Q2 25 | 1.23× | — | ||
| Q1 25 | 1.03× | — | ||
| Q4 24 | 3.81× | — | ||
| Q3 24 | 4.44× | — | ||
| Q2 24 | 4.02× | — | ||
| Q1 24 | 3.44× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
